SOLACYL 100 %
Powder for oral solution for calves and pigs
Target species
Calves and pigs.
Composition
Active substance:
Sodium salicylate 1000 mg/g
Pharmaceutical form
Powder for oral solution
White to off-white flakes
Indications for use
Calves: supportive treatment of pyrexia in acute respiratory disease, in combination with appropriate (e.g. anti-infective) therapy if necessary.
Pigs: For the treatment of inflammation in combination with concurrent antibiotic therapy.
Contraindications
Do not administer in case of severe liver and kidney disorder.
Do not administer in case of gastrointestinal ulcerations and chronic gastrointestinal disorders.
Do not administer in case of malfunction of the hematopoetic system, coagulopathie, haemorrhagic diathesis.
Do not use sodium salicylates in neonates or calves less than 2 weeks of age.
Do not use in piglets of less than 4 weeks of age.
Amounts to be administered and administration route
Calves: 40 mg sodium salicylate per kg bodyweight once daily, for 1 to 3 days.
Administration: orally in drinking water or milk(replacer).
Pigs: 35 mg sodium salicylate per kg bodyweight per day, for 3 to 5 days.
Administration: orally in drinking water.
Alternatively Solacyl can also be administered with the drinking water as pulse medication. Half of the calculated total daily amount of powder is mixed with 5-10 litres of clean water and stirred until evenly dispersed. This solution is then added, whilst stirring, into an amount of drinking water that will be consumed within approximately 3-4 hours and administered twice daily. Maximum solubility of Solacyl in water is approximately 100 g/litre.
The use of suitably calibrated weighing equipment for the administration of the calculated amount of sodium salicylate is recommended.
Special precautions to be taken by the person administering the veterinary medicinal product to animals
People with known hypersensitivity to sodium salicylate or correlated pharmaceuticals (e.g. aspirin) should avoid contact with the veterinary medicinal product. Irritation of the skin, eye, and respiratory tract might occur. During preparation and mixing of the product, direct contact with the skin and eyes, and direct inhalation of the powder should be avoided. It is recommended to wear gloves, safety glasses, and a dust mask. Wash accidental exposure to skin immediately with water. In the event of accidental eye contact, the user is advised to wash the eye with plenty of water for 15 minutes, and seek medical advice if irritation persists. During administration of the medicine as reconstituted product in drinking water or milk (replacer) to the animals skin contact should be prevented by wearing gloves. Wash accidentally exposed skin immediately with water.
Special precautions for use in animals
Do not administer to neonates or to very young calves less than 2 weeks of age and piglets less than 4 weeks of age. Given that sodium salicylate may inhibit clotting of blood, it is recommended that elective surgery should not be performed on animals within 7 days after the end of treatment.
Adverse reactions (frequency and seriousness)
Gastrointestinal irritation may occur especially in animals with pre-existing gastrointestinal disease. Such irritation may clinically be manifested by production of black manure due to blood loss in the gastrointestinal tract. Inhibition of normal blood clotting may occur incidentally. If this effect occurs it will be reversible and effects will diminish within approximately 7 days.
Use during pregnancy or lactation
The use is not recommended during pregnancy and lactation because laboratory studies in rats have shown evidence of teratogenic and foetotoxic effects. Salicylic acid crosses the placenta and is excreted with the milk. Half-life in the new-born is longer and thus toxicity symptoms may occur much sooner. Furthermore platelet aggregation is inhibited and bleeding time increased, a situation which is not favourable during hard delivery / caesarean section. Finally some studies indicate that delivery is postponed.
Interactions with other veterinary medicinal products and other forms of interaction
Concurrent administration of potentially nephrotoxic drugs (e.g. aminoglycosides) should be avoided. Salicylic acid is highly plasma (albumin) bound and competes with a variety of compounds for plasma protein binding sites (e.g. ketoprofen). Plasma clearance of salicylic acid has been reported to increase in combination with corticosteroids possible due to induction of metabolism of salicylic acid. Concurrent use with other NSAIDs is not recommended, because of increased risk of gastro-intestinal ulcers. Drugs which effect blood clotting should not be used in combination with sodium salicylate.
Overdose (symptoms, emergency procedures, antidotes) if necessary
Calves tolerate dosages up to 80 mg/kg for 5 days or 40 mg/kg for 10 days without any adverse effects. Pigs tolerate dosages up to 175 mg/kg for up to 10 days without any significant adverse effects. In case of an acute overdose intravenous bicarbonate infusion results in a higher clearance of salicylic acid by alkalisation of the urine and may be beneficial in correcting (secondary metabolic) acidosis.
Withdrawal periods
Pigs: meat and offal: zero days
Calves: meat and offal: zero days
Do not use in cows producing milk for human consumption.
